Hepatitis C: be positively aware of the risk of transmission and treatment.
Johnson
Bethsheba
B
D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D006526:Hepatitis C / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors; D014481:United States
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin